Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study, The Lancet Respiratory Medicine

Adults with asthma who had ≥2 oral corticosteroid courses in the past 2 years were at an increased risk of COVID-19 ICU admission or death (adjusted HR 1.27; 95% CI 1.09–1.48); authors suggest those with a recent asthma attack should be considered a priority group for boosters.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news